Haifa, Israel

Maya Schiller

This inventor holds 3 USPTO granted patents. Top assignees: Health Corporation - Rambam, Technion Research & Development Foundation Ltd, Other. Active years: 2020-2025.


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2020-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Maya Schiller: Innovator in Neuronal Modulation

Introduction

Maya Schiller is a prominent inventor based in Haifa, Israel. She has made significant contributions to the field of neuronal modulation, particularly in the context of immune response. With a total of 3 patents, her work is paving the way for innovative therapeutic approaches.

Latest Patents

Maya Schiller's latest patents focus on a method for modulating an immune response by activating or inhibiting dopaminergic neurons in the Ventral Tegmental Area (VTA). This method involves modulating the activity, abundance, or both of various immune cells, including natural killer cells, CD8 T-cells, CD4 T-cells, B-cells, dendritic cells, macrophages, and granulocytes. This innovative approach has the potential to significantly impact immune response modulation.

Career Highlights

Throughout her career, Maya has worked with esteemed organizations such as Technion Research & Development Foundation Ltd and Rambam Health Care Campus. Her experience in these institutions has allowed her to develop and refine her groundbreaking research in neuronal modulation.

Collaborations

Maya has collaborated with notable colleagues, including Asya Rolls and Tamar Ben Shannan. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Maya Schiller is a trailblazer in the field of neuronal modulation, with her innovative patents and collaborations highlighting her significant contributions. Her work continues to inspire advancements in the understanding of immune responses.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…